Building Strong Partnerships | Invetech & General Fluidics

Client

Product

On this page

Building Strong Partnerships | Invetech & General Fluidics

Spotlighting the Invetech and General Fluidics collaboration: What makes trust work in a high-stakes partnership. Robert Granier, CEO, General Fluidics, shares his perspective.

Invetech works with diagnostics and cell and gene therapy companies in their quest to bring novel IVD devices and life-saving therapies to market from early feasibility through scale manufacturing and lifecycle support. One integrated team, one point of accountability, at every stage.

General Fluidics is a Boston-based diagnostic company that spun out of Massachusetts General Hospital in 2018. The company is focused on making diagnostic testing more accessible for all patients.

Ready to get started?

From challenge to breakthrough

Cell Therapy QC Automation: Getting Integration Right

Cell Therapy QC Automation: Getting Integration Right Authored By: Félix A. Montero-Julian, PhD, VP Scientific Affairs and R&D, Accellix Geoffrey Stephens, PhD, MBA, CEO & Founder, AiCella, Inc. Michelle Duquette, PhD, Chief Scientist, Cell Therapy, Invetech Matt Yeung, Senior Principal...

View case study

Choosing a Diagnostic Development Partner | Invetech & General Fluidics

We understand what's required to bring a promising assay from a lab to a commercially ready product. But that alone isn't sufficient for market acceptance: great products demand more....

View case study

Integration of a Rapid Real-time PCR Module into Point-of-Care Instruments

Integration of a Rapid Real-time PCR Module into Point-of-Care Instruments Authored by: Damian Verdnik, PhD, Vice President, Diagnostics, Invetech Stuart Knowles, Lead Principal Mechanical Engineer, Invetech Tim Lee, Lead Systems Engineer, Invetech Scott Thompson, Principal Software Engineer, Invetech Summary 40...

View case study

Scaling Cell and Gene Therapy: The Future of Automation and Collaboration

We understand what's required to bring a promising assay from a lab to a commercially ready product. But that alone isn't sufficient for market acceptance: great products demand more....

View case study

Invetech – Get winning diagnostic products to market. Together.

We understand what's required to bring a promising assay from a lab to a commercially ready product. But that alone isn't sufficient for market acceptance: great products demand more....

View case study

Bridging the gap: How innovation-driven partnerships fuel the pace of cell therapy manufacturing

Successfully automating a cell therapy manufacturing program requires flexibility, process understanding, and collaboration to push boundaries and unlock new possibilities...

View case study